openPR Logo
Press release

FlyPharma 2024: Uniting Pharma and Cargo Innovators in Vienna

08-29-2024 03:59 PM CET | Health & Medicine

Press release from: Samedan Ltd.

FlyPharma 2024: Uniting Pharma and Cargo Innovators in Vienna

The FlyPharma Conference is set to return this year, bringing together global leaders, innovators, and professionals from the pharmaceutical and cargo logistics industries in the historic city of Vienna. This prestigious event will explore groundbreaking solutions and foster collaboration among industry stakeholders, pushing the boundaries of what's possible in pharma logistics.

The event will kick off with an insightful series of workshops designed to provide participants with hands-on experience and in-depth understanding of critical topics. Bernhard Zoidl will lead a workshop on the importance of risk assessment in pharmaceutical supply chains, focusing on the intersection of risk, regulatory compliance, and collaboration across stakeholders. Meanwhile, Frank van Gelder, Secretary General of Pharma.Aero, will guide attendees through innovative approaches to turning business strategies into actionable plans, emphasizing the creation of visionary strategies and navigating organizational change.

In addition to these workshops, FlyPharma 2024 will feature thought-provoking panel discussions that address the most pressing issues in the industry. One such panel, moderated by CΓ©line Crahay, will examine how to synergize pharma shipment contingency plans with crisis management within air freight logistics, exploring strategies to enhance supply chain resilience during disruptions. The second panel, led by Dr. Zvonimir Majic, will focus on the ethical considerations and challenges surrounding the adoption of AI in pharma logistics, offering insights into how these technologies can be leveraged for improved shipping solutions and risk management.

The conference will additionally include keynote sessions from industry leaders such as Vatsala Sadasivan of Sanofi and Luiz Barberini of Bayer, who will share their expertise on topics including operational excellence in R&D logistics and emerging trends in pharma sourcing and procurement. Networking opportunities will abound, with sponsored breaks by industry leaders like Etihad Cargo - one of the world's leading pharma cargo airlines, and DoKaSch Temperature Solutions providing ample time for attendees to connect and collaborate.

A highlight of FlyPharma 2024 will be the exclusive Gala Dinner at the magnificent Palais Ferstel on the evening of October 23rd. This luxurious event will offer attendees the chance to network in an elegant setting while enjoying a gourmet meal, live entertainment, and speeches from distinguished industry figures. The following day, participants will have the opportunity to visit the Vienna Airport pharma cargo facilities for a site tour.

FlyPharma 2024 promises to be an essential event for anyone involved in the pharmaceutical and logistics sectors, offering unparalleled insights, innovative solutions, and networking opportunities. Join us in Vienna this October to be part of the future of pharma and cargo.

For more information and to register, please visit the FlyPharma website.
Register now to secure your place at https://flypharmaeurope.com/tickets

Press contact information:
Ellen Taurich, Conference Producer, email: ellen@samedanltd.com
Simon Caplan, Sponsorship Opportunities, email: simon@samedanltd.com

Samedan Ltd. 44 Maiden Ln
London

Specialist pharmaceutical publisher Samedan Ltd is a dynamic, forward-thinking company that produces a range of market-leading magazines for senior and middle-management professionals across the global pharma and life sciences sectors.

Established in 1996, it has four established print and digital titles: Pharmaceutical Manufacturing and Packing Sourcer, International Clinical Trials (incorporating European Pharmaceutical Contractor), European Biopharmaceutical Review and Innovations in Pharmaceutical Technology.

These analysis-driven magazines cover the latest trends and developments affecting our global audience of contract research, pharma and biotech practitioners - from early-stage research and clinical trials, to manufacture, supply and beyond. Regulatory compliance, operational considerations, outsourcing trends, market entry and cutting-edge technologies are among the many subjects covered.

In 2013, the company extended its range with the acquisition of the Pharmafile portfolio, consisting of the monthly newspaper Pharmafocus, www.pharmafile.com and the Pharmafile directory. A leading portal for the pharmaceutical sector, industry professionals can gain access to pharma news, events and service company listings.

In 2021, Samedan Ltd became part of PMGroup Worldwide Ltd and Datateam Media Group. The acquisition brings together three publishing powerhouses in the pharmaceutical and healthcare sector. As well as joining forces with established titles like PME, PharmaTimes and digital products PMLiVE and pharmatimes.com, PMGroup run a number of awards programmes which recognise best practice in the pharma and healthcare sectors. The union has allowed all brands to expand their readership and their live, virtual and hybrid events and award schemes.

www.samedanltd.com

FlyPharma Conferences
The first FlyPharma Conference was launched in September 2015 at London Heathrow, pooling Samedan's broad readership across the pharmaceutical and logistics/cargo industries. One title in particular complements the conference's theme well and provided the basis of the FlyPharma concept: Pharmaceutical Manufacturing and Packing Sourcer (PMPS).

PMPS offers extensive pharmaceutical experience from a manufacturing, packaging and logistics perspective, and particularly relevant are its cargo-related readers - forwarders, handlers, airports and carriers. Other supporting titles from the Samedan and PMGroup portfolio include Pharmafocus, PharmaTimes and PME, all of which offer an audience of pharma industry professionals with a diverse range of backgrounds and provide both thought-led features and news-driven energy. Together, these publications support FlyPharma as media partners and provide a strong base for opening up communication between two sectors (pharma and cargo) that depend on each other for success.

In 2018, FlyPharma expanded to three regional events: Asia, Europe and US. Each conference was a success and was met with extremely positive feedback from the industry. FlyPharma Europe took place again in 2019 in Copenhagen, in its largest event to date. After a break in response to the challenges of COVID-19, FlyPharma Europe returned in 2022 and took place in Leipzig, Germany on 20-21 September, followed by FlyPharma Europe 2023 in Vienna, Austria on 10-11 October. All events cover global pharma supply chain challenges and collaborative opportunities, but each focuses on how that particular region's unique characteristics both impact and fit within a worldwide marketplace.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release FlyPharma 2024: Uniting Pharma and Cargo Innovators in Vienna here

News-ID: 3639329 • Views: …

More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDΒ 22.32Β Billion by 2024. The valuation is expected to reach USDΒ 47.79Β Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…